Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €36.98 | €70.00 | 89.317% |
Laboratory Corp. Of America (labcorp) | 11 | 0 | 0 | 0 | €197.00 | €237.94 | 20.782% |
Idexx Laboratories Inc. | 12 | 0 | 2 | 0 | €476.50 | €550.70 | 15.573% |
Eli Lilly Corp. | 49 | 0 | 6 | 0 | €748.80 | €786.51 | 5.035% |
Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €1.96 | €8.55 | 336.217% |
Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.57 | €4.62 | 1.006% |
Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.54 | €12.18 | 379.465% |
Molina Healthcare | 12 | 1 | 1 | 0 | €306.40 | €366.73 | 19.689% |
Align Technology | 15 | 2 | 0 | 0 | €236.40 | €345.95 | 46.341% |
Staar Surgical Co. | 12 | 1 | 1 | 0 | €37.97 | €49.33 | 29.911% |
VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.59 | €3.00 | 408.475% |
Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
R1 RCM Inc. | 19 | 0 | 0 | 0 | €11.40 | €17.21 | 50.988% |
Biolife Solutions Inc | 1 | 0 | 1 | 0 | €19.90 | - | - |
Pro-Dex Inc. | 15 | 0 | 0 | 0 | €17.50 | - | - |
Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €71.04 | €100.00 | 40.766% |
Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | €34.00 | €45.98 | 35.235% |
Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.51 | €3.70 | 145.033% |
Merck & Co. Inc. | 28 | 1 | 0 | 0 | €119.00 | €124.92 | 4.977% |
Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.75 | €24.13 | 63.670% |
Verastem Inc. | 10 | 0 | 2 | 0 | €4.02 | €24.63 | 512.806% |
Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.80 | €4.16 | 131.178% |
Abbott Laboratories | 17 | 0 | 1 | 0 | €95.51 | €116.71 | 22.200% |
Cigna Corp. | 16 | 0 | 2 | 0 | €306.80 | €342.35 | 11.588% |